NOTCH1 and leukemia: Using flow cytometry, we demonstrated that cytarabine did not induce a reduction in NOTCH1 receptors, unlike CAD204520, which reinforces CAD204520’s specificity toward MLLr leukemia cells via NOTCH1 (Figure 3B).